220 related articles for article (PubMed ID: 16951254)
1. Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression.
Takeda S; Chen DY; Westergard TD; Fisher JK; Rubens JA; Sasagawa S; Kan JT; Korsmeyer SJ; Cheng EH; Hsieh JJ
Genes Dev; 2006 Sep; 20(17):2397-409. PubMed ID: 16951254
[TBL] [Abstract][Full Text] [Related]
2. Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis.
Dong Y; Van Tine BA; Oyama T; Wang PI; Cheng EH; Hsieh JJ
Cell Res; 2014 Nov; 24(11):1354-66. PubMed ID: 25267403
[TBL] [Abstract][Full Text] [Related]
3. Regulation of MLL/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia.
Zhao Z; Wang L; Volk AG; Birch NW; Stoltz KL; Bartom ET; Marshall SA; Rendleman EJ; Nestler CM; Shilati J; Schiltz GE; Crispino JD; Shilatifard A
Genes Dev; 2019 Jan; 33(1-2):61-74. PubMed ID: 30573454
[TBL] [Abstract][Full Text] [Related]
4. Unraveling the Activation Mechanism of Taspase1 which Controls the Oncogenic AF4-MLL Fusion Protein.
Sabiani S; Geppert T; Engelbrecht C; Kowarz E; Schneider G; Marschalek R
EBioMedicine; 2015 May; 2(5):386-95. PubMed ID: 26137584
[TBL] [Abstract][Full Text] [Related]
5. Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression.
Hsieh JJ; Cheng EH; Korsmeyer SJ
Cell; 2003 Oct; 115(3):293-303. PubMed ID: 14636557
[TBL] [Abstract][Full Text] [Related]
6. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.
Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML
Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140
[TBL] [Abstract][Full Text] [Related]
7. Biphasic MLL takes helm at cell cycle control: implications in human mixed lineage leukemia.
Liu H; Takeda S; Cheng EH; Hsieh JJ
Cell Cycle; 2008 Feb; 7(4):428-35. PubMed ID: 18235233
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of human Taspase1, a crucial protease regulating the function of MLL.
Khan JA; Dunn BM; Tong L
Structure; 2005 Oct; 13(10):1443-52. PubMed ID: 16216576
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the catalytically impaired Taspase1 T234V or Taspase1 D233A variants does not have a dominant negative effect in T(4;11) leukemia cells.
Bier C; Hecht R; Kunst L; Scheiding S; Wünsch D; Goesswein D; Schneider G; Krämer OH; Knauer SK; Stauber RH
PLoS One; 2012; 7(5):e34142. PubMed ID: 22570686
[TBL] [Abstract][Full Text] [Related]
10. Taspase1 functions as a non-oncogene addiction protease that coordinates cancer cell proliferation and apoptosis.
Chen DY; Liu H; Takeda S; Tu HC; Sasagawa S; Van Tine BA; Lu D; Cheng EH; Hsieh JJ
Cancer Res; 2010 Jul; 70(13):5358-67. PubMed ID: 20516119
[TBL] [Abstract][Full Text] [Related]
11. The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis.
Daser A; Rabbitts TH
Semin Cancer Biol; 2005 Jun; 15(3):175-88. PubMed ID: 15826832
[TBL] [Abstract][Full Text] [Related]
12. The Mll-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric mice.
Kong CT; Sham MH; So CW; Cheah KS; Chen SJ; Chan LC
Leukemia; 2006 Oct; 20(10):1829-39. PubMed ID: 16888613
[TBL] [Abstract][Full Text] [Related]
13. Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations.
Dorrance AM; Liu S; Yuan W; Becknell B; Arnoczky KJ; Guimond M; Strout MP; Feng L; Nakamura T; Yu L; Rush LJ; Weinstein M; Leone G; Wu L; Ferketich A; Whitman SP; Marcucci G; Caligiuri MA
J Clin Invest; 2006 Oct; 116(10):2707-16. PubMed ID: 16981007
[TBL] [Abstract][Full Text] [Related]
14. Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.
Santillan DA; Theisler CM; Ryan AS; Popovic R; Stuart T; Zhou MM; Alkan S; Zeleznik-Le NJ
Cancer Res; 2006 Oct; 66(20):10032-9. PubMed ID: 17047066
[TBL] [Abstract][Full Text] [Related]
15. The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression.
Xia ZB; Popovic R; Chen J; Theisler C; Stuart T; Santillan DA; Erfurth F; Diaz MO; Zeleznik-Le NJ
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):14028-33. PubMed ID: 16169901
[TBL] [Abstract][Full Text] [Related]
16. Cleavage of TFIIA by Taspase1 activates TRF2-specified mammalian male germ cell programs.
Oyama T; Sasagawa S; Takeda S; Hess RA; Lieberman PM; Cheng EH; Hsieh JJ
Dev Cell; 2013 Oct; 27(2):188-200. PubMed ID: 24176642
[TBL] [Abstract][Full Text] [Related]
17. Taspase1 orchestrates fetal liver hematopoietic stem cell and vertebrae fates by cleaving TFIIA.
Niizuma H; Searleman AC; Takeda S; Armstrong SA; Park CY; Cheng EH; Hsieh JJ
JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34156981
[TBL] [Abstract][Full Text] [Related]
18. Histone and DNA methylation defects at Hox genes in mice expressing a SET domain-truncated form of Mll.
Terranova R; Agherbi H; Boned A; Meresse S; Djabali M
Proc Natl Acad Sci U S A; 2006 Apr; 103(17):6629-34. PubMed ID: 16618927
[TBL] [Abstract][Full Text] [Related]
19. Allosteric inhibition of Taspase1's pathobiological activity by enforced dimerization in vivo.
Bier C; Knauer SK; Wünsch D; Kunst L; Scheiding S; Kaiser M; Ottmann C; Krämer OH; Stauber RH
FASEB J; 2012 Aug; 26(8):3421-9. PubMed ID: 22623586
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic dysregulation of leukaemic HOX code in MLL-rearranged leukaemia mouse model.
Ng RK; Kong CT; So CC; Lui WC; Chan YF; Leung KC; So KC; Tsang HM; Chan LC; Sham MH
J Pathol; 2014 Jan; 232(1):65-74. PubMed ID: 24122813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]